Evidence map›Paper›PMID 31876231›Full record

ArticleCell cycle (Georgetown, Tex.)2020

Receptor protein tyrosine phosphatases control Purkinje neuron firing.

Alexander S Brown, Pratap Meera, Gabe Quinones, Jessica Magri, Thomas S Otis, Stefan M Pulst, Anthony E Oro

Abstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander S BrownProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Pratap MeeraDepartment of Neurobiology, University of California, Los Angeles, CA, USA.
Gabe QuinonesProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Jessica MagriProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Thomas S OtisSainsbury Wellcome Centre for Neural Circuits and Behavior, University College London, London, UK.
Stefan M PulstDepartment of Neurology, University of Utah Medical Center, Salt Lake City, UT, USA.
Anthony E OroProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-6261-138X

Funding

BEG4/MIM FUNCTION IN EPITHELIAL NEOPLASIAR01AR052785 · NIAMS · STANFORD UNIVERSITY · PI ORO, ANTHONY E · 2007 to 2018
$4.0M
Spinocerebellar Ataxia Type 2 Gene and Gene ProductR37NS033123 · NINDS · UNIVERSITY OF UTAH · PI PULST, STEFAN M. · 2014 to 2020
$3.6M
Antisense Oligonucleotides for treating Spinocerebellar Ataxia Type 2U01NS103883 · NINDS · UNIVERSITY OF UTAH · PI PULST, STEFAN M., SCOLES, DANIEL R · 2018 to 2020
$1.9M
Cerebellar contributions to movement explored with patterned optical manipulationR01NS090930 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOLSHANI, PEYMAN · 2014 to 2018
$1.6M
NIAMS NIH HHS R01 AR052785NINDS NIH HHS R01 NS090930NINDS NIH HHS R37 NS033123NINDS NIH HHS U01 NS103883
6 · The paper itself

Abstract

Spinocerebellar ataxias (SCA) are a genetically heterogeneous family of cerebellar neurodegenerative diseases characterized by abnormal firing of Purkinje neurons and degeneration. We recently demonstrated the slowed firing rates seen in several SCAs share a common etiology of hyper-activation of the Src family of non-receptor tyrosine kinases (SFKs). However, the lack of clinically available neuroactive SFK inhibitors lead us to investigate alternative mechanisms to modulate SFK activity. Previous studies demonstrate that SFK activity can be enhanced by the removal of inhibitory phospho-marks by receptor-protein-tyrosine phosphatases (RPTPs). In this Extra View we show that MTSS1 inhibits SFK activity through the binding and inhibition of a subset of the RPTP family members, and lowering RPTP activity in cerebellar slices with peptide inhibitors increases the suppressed Purkinje neuron basal firing rates seen in two different SCA models. Together these results identify RPTPs as novel effectors of Purkinje neuron basal firing, extending the MTSS1/SFK regulatory circuit we previously described and expanding the therapeutic targets for SCA patients.

Indexed as

Action PotentialsAnimalsCell Line, TumorEnzyme InhibitorsMiceMicrofilament ProteinsNeoplasm ProteinsProtein BindingProtein Tyrosine PhosphatasesPurkinje CellsSpinocerebellar AtaxiasEnzyme InhibitorsMicrofilament ProteinsMtss1 protein, mouseNeoplasm ProteinsProtein Tyrosine PhosphatasesMtss1neurodegenerationReceptor protein tyrosine phosphatasespinocerebellar ataxiaSrc family kinase

Identifiers

PMID31876231
PMCPMC6961678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.